EXHIBIT
10.2


 


DEMAND
NOTE


 


4DMED,
LTD, a Hong Kong corporation (the “Company,” which term includes any successor entity), for value received promises
to pay to 4DMED, Ltd., a Nevada corporation, or its assigns (the “Holder”), the principal sum of FOUR MILLION FIVE
HUNDRED THOUSAND DOLLARS ($4,500,000), and to pay interest on the outstanding principal amount of this Note in accordance with
Section 1 hereof. All outstanding principal and accrued interest hereunder shall be due and payable on DEMAND. The Holder shall
maintain accounts evidencing the date and amount of the loan made hereunder which account shall be prima facie evidence
of the amounts due hereunder, provided, however, that the failure to maintain such accounts or any error therein, shall not affect
the Company’s obligations to repay (with applicable interest) the amounts loaned by the Holder to the Company hereunder. 


 


Section
1.    Interest; Optional Prepayments


 


This
Note shall bear no interest.


 


Section
2.     Method of Payment


 


The
Company will pay principal and interest in money of the United States that at the time of payment is legal tender for payment
of public and private debts to such account free and clear of and without any reduction for any taxes, levies, imports, deduction
withholding or charges, and in such manner as the Holder may from time to time direct by written notice. If a payment date is
a Saturday, a Sunday or a legal holiday at a place of payment, payment may be made at that place on the next succeeding day that
is not a Saturday, a Sunday or a legal holiday (a “Business Day”), and interest shall accrue for the intervening period. 


 


Section
3.    Representations and Warranties Intending that the Holder rely upon the following representations
and warranties, the Company represents and warrants to the Holder that: 


 


(a)
the Company is a Hong Kong corporation duly organized and validly existing in good standing under the laws of its organization and possesses
all requisite corporate power and authority to execute, deliver and perform this Note. 


 


(b)
The execution, delivery and performance of this Note have been duly authorized by all necessary and appropriate corporate action
by and on behalf of the Company. The Note does not conflict with, nor will the execution, delivery or performance of this Note
by the Company constitute a breach or default under, or a violation of, any provision of the Company’s articles of incorporation
or bylaws or any other agreement, court order, law, rule or regulation to which the Company is a party or by which it or any of
its properties may be bound or to which it may be subject. 



    1


     


    


(c)
No authorization, approval, waiver or other action to or by, and no notice to or filing with, any governmental agency or authority
or regulatory body is required to permit, or is a condition precedent to, the granting of this Note to or for the benefit of the
Holder, the execution, delivery or performance of this Note by the Company, or the exercise by the Holder of its rights and remedies
hereunder or thereunder. 


 


Section
4.    Waivers; Amendments


 


The
Company expressly waives presentment for payment, notice of dishonor, protest, notice of protest, diligence of collection and
any other notice of any kind, and hereby consents to any number of renewals or extensions of time of payment hereof, which renewals
and extensions shall not affect the liability of any party hereto. No amendment to this Note and no waiver of any provision hereof
may be made without the prior written consent of all of the members of the Holder. Any waiver of any kind or character on the
part of the Holder in respect of this Note must be in writing and shall be effective only to the extent specifically set forth
in such writing. No delay on the part of the Holder in exercising any of its powers or rights, and no partial or single exercise,
shall constitute a waiver 


 


Section
5.    Severability


 


If
any provision of this Note or the application thereof is held by a court of competent jurisdiction to be invalid or unenforceable,
the remaining provisions hereof shall not be affected thereby, and each provision of this Note shall be valid and enforceable
to the fullest extent permitted by law. 


 


Section
6.    Notices


 


Any
notices or other communications hereunder shall be in writing and shall be deemed to have been duly given if transmitted by facsimile
to the number specified below or to a number specified to replace such number. Notices to the Holder shall be given to 4DMED,
Ltd. at 4650 Wedekind Rd., Sparks, NV 89431, Telephone: 775-882-7549, Facsimile: 775-331-8601, Attn: Treasurer.


 


Section
7.    Governing Law; Successors and Assigns


 


This
Note shall be deemed a contract under, and shall be governed and construed in accordance with, the laws of the State of Nevada
without giving effect to principles of conflicts of laws. The Note shall be binding upon the parties hereto and their respective
successors and assigns; provided, however, that the Company may not transfer its interest or obligations hereunder without the
consent of the Holder. 


 


[Signatures
on following page]



    2


     


    


IN
WITNESS WHEREOF, the Company has caused this Note to be signed by its duly authorized officer. 


 


Dated:
July 1, 2017 


 


	 	4DMED,
    LTD., a Hong Kong corporation
	 	 	 
	 	By:	/s/ Yuen
May Cheung
	 

	 	 	Its:
        Director




3